NDC Package 60687-534-78 Atovaquone

Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
60687-534-78
Package Description:
7 TRAY in 1 CASE / 6 CUP, UNIT-DOSE in 1 TRAY (60687-534-52) / 5 mL in 1 CUP, UNIT-DOSE (60687-534-40)
Product Code:
Proprietary Name:
Atovaquone
Non-Proprietary Name:
Atovaquone
Substance Name:
Atovaquone
Usage Information:
Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath.
11-Digit NDC Billing Format:
60687053478
NDC to RxNorm Crosswalk:
  • RxCUI: 308429 - atovaquone 750 MG in 5 mL Oral Suspension
  • RxCUI: 308429 - atovaquone 150 MG/ML Oral Suspension
  • RxCUI: 308429 - atovaquone 1500 MG per 10 ML Oral Suspension
  • RxCUI: 308429 - atovaquone 750 MG per 5 ML Oral Suspension
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    American Health Packaging
    Dosage Form:
    Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA210692
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-21-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    60687-534-362 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY (60687-534-46) / 5 mL in 1 CUP, UNIT-DOSE (60687-534-40)

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 60687-534-78?

    The NDC Packaged Code 60687-534-78 is assigned to a package of 7 tray in 1 case / 6 cup, unit-dose in 1 tray (60687-534-52) / 5 ml in 1 cup, unit-dose (60687-534-40) of Atovaquone, a human prescription drug labeled by American Health Packaging. The product's dosage form is suspension and is administered via oral form.

    Is NDC 60687-534 included in the NDC Directory?

    Yes, Atovaquone with product code 60687-534 is active and included in the NDC Directory. The product was first marketed by American Health Packaging on October 21, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 60687-534-78?

    The 11-digit format is 60687053478. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-260687-534-785-4-260687-0534-78